在两个中心实施综合血管腔内主动脉项目并在开窗分支血管腔内主动脉修复期间保持临床卓越
该研究回顾性分析了2013至2023年两中心629例复杂腹主动脉及胸腹主动脉瘤行开窗或分支血管腔内主动脉修复(FB-EVAR)的患者,比较中心1(2013-2020年)与中心2(2020-2023年)的结局。结果显示两中心技术成功率相似(97.9% vs 98.1%,p=.91),早期死亡率1.1%,死亡率和主要不良事件率无差异,尽管新中心病例风险更高、范围更广。
要点
- 两中心FB-EVAR技术成功率相似(97.9% vs 98.1%,p=.91),早期死亡率1.1%。
- 中心2收治更多美国麻醉医师学会分级≥3级、遗传性主动脉疾病、慢性夹层后动脉瘤及胸腹主动脉瘤患者。
- 两中心1年死亡率(91% vs 89%,p=.71)和再干预率(亚分布风险比1.30,p=.21)相似。
核心结论
- FB-EVAR的死亡率和致残性并发症风险均较低;在新中心建立综合血管腔内主动脉项目后,尽管病例风险更高、范围更广,死亡率和主要不良事件率未见差异。
研究设计与样本
- 回顾性综述,纳入2013至2023年间两中心接受FB-EVAR治疗的复杂腹主动脉及胸腹主动脉瘤患者,共629例(中心1为475例,占75.5%;中心2为154例,占24.5%)。
- 比较中心1(2013-2020年)与中心2(2020-2023年)的结局,纳入所有FB-EVAR患者,包括研究性试验及使用医师改良内移植物高危患者。
- 中位年龄74岁(四分位距68,79),男性441例(70.1%)。
主要发现
- 中心2的美国麻醉医师学会分级≥3级、遗传性主动脉疾病(p=.002)、慢性夹层后动脉瘤、既往主动脉修复、胸腹主动脉瘤(各p<.001)及症状性、较大动脉瘤(p<.021)比例均高于中心1。
- 技术成功率两中心相似(97.9% vs 98.1%;p=.91);早期死亡率为1.1%(7/629),两中心无统计学显著差异。
- 新发永久性透析(0.6% vs 2.0%)、主要卒中(0.6% vs 0.6%)和永久性截瘫(0.8% vs 2.0%)两中心均无统计学显著差异(p>.050)。
- 中心2的救治失败率为5.3%,中心1为3.5%(p=.74)。
- 两中心1年死亡率(91% vs 89%;p=.71)和再干预率(亚分布风险比1.30;p=.21)相似。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Comprehensive endovascular aortic programmes need optimal infrastructure and multidisciplinary teams to manage complex aortic aneurysms. This study assessed the implementation of such a programme in two centres and its impact on fenestrated or branched endovascular aortic repair (FB-EVAR) outcomes. METHODS: A retrospective review of patients treated for complex abdominal and thoraco-abdominal aortic aneurysms (TAAAs) by FB-EVAR between 2013 and 2023 was undertaken. All FB-EVAR patients were analysed, including investigational trials and high risk patients with physician modified endografts. Centre 1 (2013 - 2020) and Centre 2 (2020 - 2023) were compared. Primary endpoints were 30 day and or in hospital mortality and major adverse event (MAE) rates. Secondary endpoints were procedural metrics, spinal cord injuries, freedom from all cause death, failure to rescue, and one year mortality and re-intervention rates. RESULTS: A total of 629 patients were included (475, 75.5% at Centre 1 and 154, 24.5% at Centre 2). The median age was 74 years (interquartile range 68, 79) and 441 (70.1%) were male. Centre 2 had a higher proportion of American Society of Anesthesiology class ≥ 3, genetically triggered aortic diseases (p = .002), chronic post-dissection aneurysms, prior aortic repairs, TAAAs (each p < .001), and symptomatic, larger aneurysms (p < .021). Technical success rates were similar between centres (97.9% vs. 98.1%; p = .91). The early mortality rate was 1.1% (7/629) with no statistically significant difference. No statistically significant differences (p > .050) in new onset permanent dialysis (0.6% vs. 2.0%), major stroke (0.6% vs. 0.6%), and permanent paraplegia (0.8% vs. 2.0%) were observed. Failure to rescue rates were 5.3% in Centre 2 and 3.5% in Centre 1 (p = .74). The one year mortality rate (91% vs. 89%; p = .71) and re-intervention rate (sub-distribution hazard ratio 1.30; p = .21) were similar between centres. CONCLUSION: FB-EVAR was performed with low mortality and risk of disabling complication rates. No differences in mortality and MAE rates were observed after establishing a comprehensive endovascular programme, despite higher risk and more extensive cases at the new institution.
引用
- Ruiter Kanamori L, Vacirca A, Babocs D, et al. Implementation of a Comprehensive Endovascular Aortic Programme and Maintenance of Clinical Excellence during Fenestrated Branched Endovascular Aortic Repair in Two Centres. Eur J Vasc Endovasc Surg. 2024. PMID: 39571886. doi:10.1016/j.ejvs.2024.11.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。